This test analyzes your GLP1R receptor variants, GIPR rs1800437 status, FTO rs9939609 pattern, and MC4R rs17782313 positioning across 14 metabolic pathways
Learn more from our functional medicine doctor about GLP-1 medications and the future
The same active ingredient, semaglutide, is also available as an approved weight loss under the name Wegovy
A reliable platform clearly shows the product name, strength, dosage form, manufacturer details and storage guidelines
Type HTTP Expiry 2 Years Google Analytics test_cookie Used by Google to determine if the user's browser supports cookies
The key objective of SOUL was to demonstrate that oral semaglutide lowers the risk of major adverse cardiovascular events (a composite endpoint consisting of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) compared to placebo, both added to standard of care in patients with type 2 diabetes and established CVD and/or CKD